Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma.
Vida Ventures led the raise, with the venture arms of UCB, Bayer, Otsuka Pharmaceutical and Johnson & Johnson all pitching in to support SonoThera’s unique delivery system for genetic medicines.
SonoThera will use the raise to push its lead candidate for Duchenne muscular dystrophy (DMD) and an autosomal dominant polycystic kidney disease program into the clinic, the biotech announced in a June 10 release.
The Big Pharma interest stems from the potential for SonoThera’s technology to solve long-standing problems with traditional delivery systems and bring genetic medicines to bigger patient populations, the biotech’s co-founder and CEO, Kenneth Greenberg, Ph.D., told Fierce Biotech.
Viral vectors, the classic shuttle for gene therapies, are especially prone to safety concerns such as liver toxicity and are limited to a single dose because of recognition from the immune system, Greenberg explained. Both viruses and lipid nanoparticles also struggle with complex manufacturing processes, and can’t fit large amounts of DNA or RNA at once.
“Most of the large pharmas have been battling against these same challenges with their internal programs,” Greenberg said. They also recognize that SonoThera’s approach “could allow the application of gene therapy into chronic prevalent diseases with much greater populations than rare disease[s].”
SonoThera’s solution was invented by the company’s chief scientific officer and co-founder Steve Feinstein, M.D., back in the 1990s. A cardiologist, Feinstein noticed there was no way to produce contrast when using ultrasound on the heart, making imaging difficult.
He created microbubbles as a way to better view the blood-pumping organ, Greenberg told Fierce. “He created the entire field of contrast ultrasound by inventing the first two FDA-approved microbubbles.”
It wasn’t long until Feinstein recognized that the tiny bubbles could also be used to help deliver medicines, and he, Greenberg and the other co-founders teamed up to launch the company in 2022.
The process works like this, Greenberg said: naked DNA or RNA is infused into the patient’s body alongside a stream of microbubbles. Ultrasound is then beamed onto the target organ, which activates the bubbles and causes them to open gaps in the blood vessels that serve as a path to the organ’s tissues. The same ultrasound, the components of which are all already established and FDA approved, then makes the bubbles pop, opening pores in the organ’s cells that the genetic payload can slip through.
The whole procedure can be done in under an hour, according to SonoThera’s release.
“We really wanted to build a platform that would enable patient access and adoption by the clinical community without having novel hardware and additional regulatory hurdles,” the CEO said.
With $125 million more now in the safe, the biggest test is set to come for SonoThera’s unique technique. The biotech plans to launch its DMD clinical trial next year, using its bubble-assisted delivery to ship the full-length dystrophin gene to patients.
Dystrophin is the key muscle protein lacking in DMD, but the gene that makes it is too large to fit into traditional adeno-associated virus (AAV) or nanoparticle vectors. This is why existing medicines, like Sarepta Therapeutics’ Elevidys, instead use a shortened form of the gene, or why other approaches try to target specific disease-causing mutations.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
